Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is tacrolimus superior to ciclosporin microemulsion in preventing long-term acute renal transplant rejection?

Nature Clinical Practice Nephrology volume 1, pages 16–17 (2005)Cite this article

boxed-textKrämer BK et al. (2005) Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Nephrol Dial Transplant 20: 968–973

Tacrolimus is the calcineurin blocker of choice in renal transplant, because of its superior effect on acute rejection rates and its favorable risk profile compared with ciclosporin microemulsion

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Margreiter R et al. (2002) Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study. Lancet 359: 741–746

    Article  CAS  Google Scholar 

  2. Vincenti F et al. (2002) A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation 73: 775–782

    Article  CAS  Google Scholar 

  3. Mayer AD (2002) Chronic rejection and graft half-life: five year follow-up of the European Tacrolimus Multicenter Renal Study. Transplant Proc 34: 1491–1492

    Article  Google Scholar 

  4. Artz MA et al. (2004) Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. Am J Transplant 4: 937–945

    Article  CAS  Google Scholar 

  5. Rostaing L et al. (2005) Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation 79: 807–814

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloe Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. a consultant nephrologist at the Rijnmond-Zuid Medical Centre, Rotterdam, The Netherlands

    Johannes MM Boots

Authors
  1. Johannes MM Boots
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Johannes MM Boots.

Ethics declarations

Competing interests

The author has participated in trials sponsored by Fujisawa GmbH, but has never received any personal financial support from this company.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boots, J. Is tacrolimus superior to ciclosporin microemulsion in preventing long-term acute renal transplant rejection?. Nat Rev Nephrol 1, 16–17 (2005). https://doi.org/10.1038/ncpneph0016

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0016

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing